Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from NanoString Technologies

12 Health Care Stocks Moving In Tuesday's Intraday Session

Stocks That Hit 52-Week Lows On Tuesday

Stocks That Hit 52-Week Lows On Tuesday

Tuesday's session saw 184 companies set new 52-week lows.

NanoString Technologies Earnings Perspective: Return On Capital Employed

NanoString Technologies Earnings Perspective: Return On Capital Employed

Benzinga Pro data, NanoString Technologies (NASDAQ:NSTG) reported Q1 sales of $31.08 million. Earnings fell to a loss of $39.50 million, resulting in a 34.99% decrease from last quarter.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

What 4 Analyst Ratings Have To Say About NanoString Technologies

Analysts have provided the following ratings for NanoString Technologies (NASDAQ:NSTG) within the last quarter:

Recap: NanoString Technologies Q1 Earnings

NanoString Technologies (NASDAQ:NSTG) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

NanoString Technologies's Return On Capital Employed Overview

NanoString Technologies's Return On Capital Employed Overview

According to Benzinga Pro data, during Q4, NanoString Technologies (NASDAQ:NSTG) posted sales of $42.45 million. Earnings were up 6.4%, but NanoString Technologies still reported an overall loss of $29.26 million.

NanoString Technologies: Q4 Earnings Insights

NanoString Technologies: Q4 Earnings Insights

NanoString Technologies (NASDAQ:NSTG) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Organisations

B of A Securities

Hims Hers Health

Leidos Holdings

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play